“TMG’s niche focus on O&G places it in a prime position to grow its presence in the in vitro fertilisation (IVF) market across APAC. Aside from O&G, TMG aspires to expand its medical speciality and progressively flourish into a reputable full healthcare service provider,” they add.
DBS Group Research, in an unrated report, calls Thomson Medical Group (SGX:A50
) a "diamond in the rough" with a strong portfolio of healthcare assets in Singapore and Malaysia, and with potential for further growth across the region with its recent acquisition of a hospital in Vietnam.
“Thomson Medical Group has a strong reputation as one of the largest private providers of healthcare services for women and children in Singapore,” write analysts Rachel Tan and Amanda Tan in their Dec 15 note.
